Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

New Developments in Vision Research April 2019

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

PDF

Ann-Margret Ervin; Rupert W. Strauss; Mohamed I. Ahmed; David Birch; Janet Cheetham; Frederick L. Ferris III; Michael S. Ip; Glenn J. Jaffe; Maureen G. Maguire; Etienne M. Schönbach; SriniVas R. Sadda; Sheila K. West; Hendrik P.N. Scholl; for the ProgStar Study Group
TAGS: atrophy, prospective studies, eye, stargardt's disease, spectral-domain optical coherence tomography
Trans. Vis. Sci. Tech.. 2019; 8(2):16. doi: 10.1167/tvst.8.2.16

ARVO Annual Meeting Abstract July 2018

Development of Geographic Atrophy following Untreated Neovascular Age-related Macular Degeneration—Results from AREDS

Panos George Christakis; Elvira Agron; Michael L Klein; J. Peter Campbell; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4947. doi:

ARVO Annual Meeting Abstract July 2018

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Tiarnan D L Keenan; Elvira Agron; Amitha Domalpally; Traci E Clemons; Freekje Van Asten; Wai T Wong; Ronald P Danis; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6010. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration

Katherine Grace Chen; Jason Alvarez; Wai T Wong; Henry Wiley; Emily Y. Chew; Frederick L Ferris; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2423. doi:

Articles February 2017

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software

PDF

Alex S. Willoughby; Stephanie J. Chiu; Rachel K. Silverman; Sina Farsiu; Clare Bailey; Henry E. Wiley; Frederick L. Ferris, III; Glenn J. Jaffe
TAGS: software, eye, macular edema, diabetic
Trans. Vis. Sci. Tech.. 2017; 6(1):9. doi: 10.1167/tvst.6.1.9

Research Opportunities October 2016

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop

PDF

Prashant Nair; Lloyd Paul Aiello; Thomas W. Gardner; Lee M. Jampol; Frederick L. Ferris III
TAGS: diabetes mellitus, diabetes mellitus, type 2, diabetic retinopathy, united states food and drug administration, vision, visual acuity, eye, surrogate endpoints, anti-vascular endothelial growth factor therapy
Invest. Ophthalmol. Vis. Sci.. 2016; 57(13):5127-5142. doi: 10.1167/iovs.16-20356

ARVO Annual Meeting Abstract September 2016

Implementation and assessment of visual acuity screening of Ebola Virus Disease survivors utilizing the Peek Vision smartphone platform

Sina Vahedi; Allen O Eghrari; Rachel Jessica Bishop; Christopher J. Brady; Cavan S Reilly; Frederick L Ferris; Jemma Larbelee; Mosoka Fallah

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5537. doi:

ARVO Annual Meeting Abstract September 2016

Clinical characterization of Ebola-associated eye disease with spectral domain optical coherence tomography

Allen O Eghrari; Rachel Jessica Bishop; Christopher J. Brady; Vincent Ray; Mosoka Fallah; Denise Cunningham; Cavan S Reilly; Frederick L Ferris; Jemma Larbelee

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1668. doi:

ARVO Annual Meeting Abstract September 2016

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Juan E Grunwald; Benjamin J Kim; Maureen G Maguire; James A Shaffer; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin; Frederick L Ferris; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2653. doi:

ARVO Annual Meeting Abstract June 2015

A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema

Henry Wiley; Clare Bailey; Catherine A Cukras; Glenn J Jaffe; Richard W J Lee; Erin Loken; Catherine Meyerle; Darby J.S. Thompson; Wai T Wong; Frederick L Ferris

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3149. doi:

ARVO Annual Meeting Abstract June 2015

Evaluating the AREDS grading scale for age-related macular degeneration in AREDS2

Susan Vitale; Traci E Clemons; Elvira Agron; Frederick L Ferris; Amitha Domalpally; Ronald P Danis; Emily Y Chew; AREDS2 Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3794. doi:

ARVO Annual Meeting Abstract June 2015

Comparing retinal sensitivity and SDOCT volumes in the AMD Phenotype and Genotype study

Vincent Tai; Monica Bernadette Sevilla; Traci E Clemons; Emily Y Chew; Frederick L Ferris; Sina Farsiu; Cynthia A Toth

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5154. doi:

Clinical Trials January 2015

Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial

PDF

Philip A. Petrou; Denise Cunningham; Katherine Shimel; Molly Harrington; Keri Hammel; Catherine A. Cukras; Frederick L. Ferris; Emily Y. Chew; Wai T. Wong
TAGS: rapamycin, atrophy, visual acuity, eye
Invest. Ophthalmol. Vis. Sci.. 2015; 56(1):330-338. doi: 10.1167/iovs.14-15877

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Changes in Occurrence of Anti-Retinal Autoantibodies Associated with the Progression from “Dry” To “Wet” AMD

Grazyna Adamus; Emily Y Chew; Frederick L Ferris; Michael L Klein

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):78. doi:

ARVO Annual Meeting Abstract April 2014

Candidate serum protein biomarkers of age-related macular degeneration (AMD)

Tammy M Martin; Michael L Klein; Phillip A Wilmarth; Frederick L Ferris; Emily Y Chew; Ashok P Reddy; Larry L David

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):574. doi:

ARVO Annual Meeting Abstract April 2014

Intravitreal Sirolimus for the Treatment of Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration: Results of a Phase I/II Trial

Philip A Petrou; Katherine Shimel; Catherine A Cukras; Frederick L Ferris; Emily Y Chew; Wai T Wong

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5892. doi:

ARVO Annual Meeting Abstract April 2014

Rates of Vision Loss in Patients with Geographic Atrophy in AREDS and AREDS 2

David Valent; Emily Y Chew; Elvira Agron; Frederick L Ferris; Philip J Rosenfeld; Traci E Clemons; Wai T Wong; Age Related Eye Disease Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5894. doi:

ARVO Annual Meeting Abstract April 2014

Area Measurement of the Ellipsoid Zone (EZ) by SD-OCT and its Correlation with Visual Field Identifies a Potential Anatomical Endpoint for Clinical Trials in Retinitis Pigmentosa (RP)

Alexander Ho; Travis Smith; Amirhossein Hariri; Elvira Chegarnov; Frederick L Ferris; Paul Van Veldhuisen; Srinivas R Sadda; Richard G Weleber; David G Birch; VPA Clinical Trial Group, EZ Area Working Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3380. doi:

ARVO Annual Meeting Abstract April 2014

Impairment in Dark Adaptation is Associated with Age-Related Macular Degeneration Severity and Reticular Drusen

Jason Flamendorf; Elvira Agron; Shaza Al-Holou; Henry Wiley; Wai T Wong; Emily Y Chew; Frederick L Ferris; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5221. doi:

ARVO Annual Meeting Abstract April 2014

Alternative statistical approaches to determine associations of clinical testing parameters in affected versus unaffected patients

Susan Vitale; Nancy Huynh; Catherine A Cukras; Frederick L Ferris

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5345. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

Development of Geographic Atrophy following Untreated Neovascular Age-related Macular Degeneration—Results from AREDS

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop

Implementation and assessment of visual acuity screening of Ebola Virus Disease survivors utilizing the Peek Vision smartphone platform

Clinical characterization of Ebola-associated eye disease with spectral domain optical coherence tomography

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema

Evaluating the AREDS grading scale for age-related macular degeneration in AREDS2

Comparing retinal sensitivity and SDOCT volumes in the AMD Phenotype and Genotype study

Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial

Changes in Occurrence of Anti-Retinal Autoantibodies Associated with the Progression from “Dry” To “Wet” AMD

Candidate serum protein biomarkers of age-related macular degeneration (AMD)

Intravitreal Sirolimus for the Treatment of Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration: Results of a Phase I/II Trial

Rates of Vision Loss in Patients with Geographic Atrophy in AREDS and AREDS 2

Area Measurement of the Ellipsoid Zone (EZ) by SD-OCT and its Correlation with Visual Field Identifies a Potential Anatomical Endpoint for Clinical Trials in Retinitis Pigmentosa (RP)

Impairment in Dark Adaptation is Associated with Age-Related Macular Degeneration Severity and Reticular Drusen

Alternative statistical approaches to determine associations of clinical testing parameters in affected versus unaffected patients

To View More...

You must be signed into an individual account to use this feature.